milvexian
bms
['axiomatic', 'milvexian']
#esccongress | axiomatic-ssp: in this phase 2 trial treatment with milvexian was associated an approximately 30% relative risk reduction in symptomatic ischemic strokes compared to placebo. although a dose response was not observed. 
Latest research in cardiology | Breaking news, insights, interviews, live tweeting and updates from major conferences. Co-published by @ilpensiero | @think2it